LSV Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

LSV Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Buy	+146,800	New	+$1.98M	﹤0.01%	594

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

LSV Asset Management's RDY Position: Q2 2026 in Review

LSV Asset Management opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 146,800 shares worth $2.13M. The stake represents ﹤0.01% of the portfolio and ranks #594 among its holdings.

89 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

LSV Asset Management held 146,800 shares of Dr. Reddy's Laboratories worth $2.13M as of Q2 2026.
Dr. Reddy's Laboratories was a new LSV Asset Management position in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #594 holding.
89 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.